Exact Mass: 609.2049470000001
Exact Mass Matches: 609.2049470000001
Found 150 metabolites which its exact mass value is equals to given mass value 609.2049470000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Peonidin 3-rhamnoside 5-glucoside
Peonidin 3-rhamnoside 5-glucoside is found in common pea. Peonidin 3-rhamnoside 5-glucoside is isolated from peas. Isolated from peas. Peonidin 3-rhamnoside 5-glucoside is found in pulses and common pea.
Malvidin 3-glucoside-4-vinylphenol
Malvidin 3-glucoside-4-vinylphenol is found in alcoholic beverages. Malvidin 3-glucoside-4-vinylphenol is a pigment isolated from red wine made from grapes (Vitis vinifera Pigment isolated from red wine made from grapes (Vitis vinifera). Malvidin 3-glucoside-4-vinylphenol is found in grape wine, alcoholic beverages, and common grape.
QYNAD
QYNAD is an endogenous pentapeptide with the sequence Gln-Tyr-Asn-Ala-Asp (QYNAD in the international one letter code of amino acids), isolated from the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS) and Guillain-Barre syndrome (GBS). Immune mediated inflammatory neurological disorders like MS and GBS are characterized by demyelination and axonal damage. QYNAD can reversibly block voltage-gated sodium channels in a concentration-dependent manner. The blocking mechanism is a shift of the steady state inactivation curve of the sodium channels to more negative potentials, as with many local anaesthetics. QYNAD was found to reach concentrations in the CSF of MS or GBS that could subsantially block neuronal sodium channels. (PMID: 11750990) [HMDB] QYNAD is an endogenous pentapeptide with the sequence Gln-Tyr-Asn-Ala-Asp (QYNAD in the international one letter code of amino acids), isolated from the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS) and Guillain-Barre syndrome (GBS). Immune mediated inflammatory neurological disorders like MS and GBS are characterized by demyelination and axonal damage. QYNAD can reversibly block voltage-gated sodium channels in a concentration-dependent manner. The blocking mechanism is a shift of the steady state inactivation curve of the sodium channels to more negative potentials, as with many local anaesthetics. QYNAD was found to reach concentrations in the CSF of MS or GBS that could subsantially block neuronal sodium channels. (PMID: 11750990).
3-Ferulylpelargonidin 5-glucoside
3-Ferulylpelargonidin 5-glucoside is found in root vegetables. 3-Ferulylpelargonidin 5-glucoside is isolated from red radish (Raphanus sp.). Isolated from red radish (Raphanus species). 3-Ferulylpelargonidin 5-glucoside is found in root vegetables.
Isopeonidin 3-rutinoside
Isopeonidin 3-rutinoside is a polyphenol metabolite detected in biological fluids (PMID: 20428313). A polyphenol metabolite detected in biological fluids [PhenolExplorer]
Peonidin 3-(6'-p-coumaroyl-glucoside)
Peonidin 3-(6-p-coumaroyl-glucoside) is a member of the class of compounds known as anthocyanidin 3-o-6-p-coumaroyl glycosides. Anthocyanidin 3-o-6-p-coumaroyl glycosides are anthocyanidin 3-O-glycosides where the carbohydrate moiety is esterified at the C6 position with a p-coumaric acid. P-coumaric acid is an organic derivative of cinnamic acid, that carries a hydroxyl group at the 4-position of the benzene ring. Peonidin 3-(6-p-coumaroyl-glucoside) is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Peonidin 3-(6-p-coumaroyl-glucoside) can be found in common grape and grape wine, which makes peonidin 3-(6-p-coumaroyl-glucoside) a potential biomarker for the consumption of these food products.
Peonidin 3-rutinoside
Peonidin 3-rutinoside is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Peonidin 3-rutinoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Peonidin 3-rutinoside can be found in a number of food items such as european plum, blackcurrant, lima bean, and french plantain, which makes peonidin 3-rutinoside a potential biomarker for the consumption of these food products.
Peonidin 3-(6-p-coumarylglucoside)
4-(2-{6-amino-2-[1-(2-amino-2-carboxy-ethylamino)-2-carboxy-ethyl]-5-methyl-pyrimidine-4-carbonylamino}-3-hydroxy-3-(1(3)H-imidazol-4-yl)-propionylamino)-3-hydroxy-2-methyl-pentanoic acid
(2R,3R,4R,5S)-2-(6-amino-9H-purin-9-yl)-4-{[(E)-3-(1H-imidazol-4-yl)-2-propenoyl]oxy}-5-[(methylsulfinyl)methyl]tetrahydro-3-furanyl(Z)-3-(4-hydroxyphenyl)-2-methoxy-2-propenoate
Glu Glu Phe Trp
Glu Glu Trp Phe
Glu Phe Glu Trp
Glu Phe Trp Glu
Glu Trp Glu Phe
Glu Trp Phe Glu
Phe Glu Glu Trp
Phe Glu Trp Glu
Phe Trp Glu Glu
His His Met Trp
C28H35N9O5S (609.2481740000001)
His His Trp Met
C28H35N9O5S (609.2481740000001)
His Met His Trp
C28H35N9O5S (609.2481740000001)
His Met Trp His
C28H35N9O5S (609.2481740000001)
His Gln Tyr Tyr
C29H35N7O8 (609.2546990000001)
His Trp His Met
C28H35N9O5S (609.2481740000001)
His Trp Met His
C28H35N9O5S (609.2481740000001)
His Tyr Gln Tyr
C29H35N7O8 (609.2546990000001)
His Tyr Tyr Gln
C29H35N7O8 (609.2546990000001)
Met His His Trp
C28H35N9O5S (609.2481740000001)
Met His Trp His
C28H35N9O5S (609.2481740000001)
Met Trp His His
C28H35N9O5S (609.2481740000001)
Asn Gln Trp Tyr
C29H35N7O8 (609.2546990000001)
Asn Gln Tyr Trp
C29H35N7O8 (609.2546990000001)
Asn Trp Gln Tyr
C29H35N7O8 (609.2546990000001)
Asn Trp Tyr Gln
C29H35N7O8 (609.2546990000001)
Asn Tyr Gln Trp
C29H35N7O8 (609.2546990000001)
Asn Tyr Trp Gln
C29H35N7O8 (609.2546990000001)
Gln His Tyr Tyr
C29H35N7O8 (609.2546990000001)
Gln Asn Trp Tyr
C29H35N7O8 (609.2546990000001)
Gln Asn Tyr Trp
C29H35N7O8 (609.2546990000001)
Gln Trp Asn Tyr
C29H35N7O8 (609.2546990000001)
Gln Trp Tyr Asn
C29H35N7O8 (609.2546990000001)
Gln Tyr His Tyr
C29H35N7O8 (609.2546990000001)
Gln Tyr Asn Trp
C29H35N7O8 (609.2546990000001)
Gln Tyr Trp Asn
C29H35N7O8 (609.2546990000001)
Gln Tyr Tyr His
C29H35N7O8 (609.2546990000001)
Trp Glu Glu Phe
Trp Glu Phe Glu
Trp Phe Glu Glu
Trp His His Met
C28H35N9O5S (609.2481740000001)
Trp His Met His
C28H35N9O5S (609.2481740000001)
Trp Met His His
C28H35N9O5S (609.2481740000001)
Trp Asn Gln Tyr
C29H35N7O8 (609.2546990000001)
Trp Asn Tyr Gln
C29H35N7O8 (609.2546990000001)
Trp Gln Asn Tyr
C29H35N7O8 (609.2546990000001)
Trp Gln Tyr Asn
C29H35N7O8 (609.2546990000001)
Trp Tyr Asn Gln
C29H35N7O8 (609.2546990000001)
Trp Tyr Gln Asn
C29H35N7O8 (609.2546990000001)
Tyr His Gln Tyr
C29H35N7O8 (609.2546990000001)
Tyr His Tyr Gln
C29H35N7O8 (609.2546990000001)
Tyr Asn Gln Trp
C29H35N7O8 (609.2546990000001)
Tyr Asn Trp Gln
C29H35N7O8 (609.2546990000001)
Tyr Gln His Tyr
C29H35N7O8 (609.2546990000001)
Tyr Gln Asn Trp
C29H35N7O8 (609.2546990000001)
Tyr Gln Trp Asn
C29H35N7O8 (609.2546990000001)
Tyr Gln Tyr His
C29H35N7O8 (609.2546990000001)
Tyr Trp Asn Gln
C29H35N7O8 (609.2546990000001)
Tyr Trp Gln Asn
C29H35N7O8 (609.2546990000001)
Tyr Tyr His Gln
C29H35N7O8 (609.2546990000001)
Tyr Tyr Gln His
C29H35N7O8 (609.2546990000001)
3-Ferulylpelargonidin 5-glucoside
Peonidin 3-rhamnoside 5-glucoside
Isopeonidin 3-rutinoside
FM 1-43 dye
C30H49Br2N3 (609.2292994000001)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
RO 46-8443
C31H35N3O8S (609.2144750000001)
Ro 46-8443 is the first non-peptide endothelin ETB receptor selective antagonist. Ro 46-8443 displays an at least 100-fold selectivity for ETB (IC50: 34-69 nM) over ETA receptors (IC50: 6800 nM)[1][2].
alpha-L-Fucp-(1->4)-[beta-D-Galp3S-(1->3)]-beta-D-GlcpNAc
C20H35NO18S (609.1574770000001)
peonidin-3-O-(6-O-trans-p-coumaryl-beta-D-glucoside)
beta-D-Galp3S-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc
C20H35NO18S (609.1574770000001)
alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-6-O-sulfo-beta-D-glucosamine
C20H35NO18S (609.1574770000001)
2-[(2S,4aS,12aR)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
3-[(4S,5S)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-N,N-dimethylbenzamide
beta-D-Galp3S-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc
C20H35NO18S (609.1574770000001)
3-[(4R,5R)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-N,N-dimethylbenzamide
4-chloro-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
2-[(2S,4aR,12aR)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
4-chloro-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
4-chloro-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-[(2-thiophen-2-ylacetyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromenium-3-yl 6-O-[(2Z)-3-(4-hydroxyphenyl)prop-2-enoyl]-beta-D-glucopyranoside
2-[(2S,4aR,12aS)-5-methyl-6-oxo-8-[(2-thiophen-2-ylacetyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
2-[(2S,4aS,12aS)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
2-[(2R,4aR,12aS)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
2-[(2R,4aR,12aR)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[(4-phenylphenyl)methyl]acetamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
3-[(4S,5R)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-N,N-dimethylbenzamide
4-chloro-N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
C28H34F3N5O5S (609.2232630000001)
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1-methyl-4-imidazolesulfonamide
3-[(4R,5S)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-N,N-dimethylbenzamide
3-[(4S,5S)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-N,N-dimethylbenzamide
3-[(4R,5R)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-N,N-dimethylbenzamide
3-[(4S,5R)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-N,N-dimethylbenzamide
3-[(4R,5S)-5-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-N,N-dimethylbenzamide
4-chloro-N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
4-chloro-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
4-chloro-N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylbenzenesulfonamide
alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-D-GlcpNAc
C20H35NO18S (609.1574770000001)
alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-GlcpNAc6S
C20H35NO18S (609.1574770000001)
beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc6S
C20H35NO18S (609.1574770000001)
alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->3)-D-GlcpNAc
C20H35NO18S (609.1574770000001)
alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-beta-D-GlcpNAc
C20H35NO18S (609.1574770000001)
alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc6S
C20H35NO18S (609.1574770000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1,3-dihydroxy-2-methyl-4-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)butan-2-yl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[3,4-dihydroxy-3-methyl-1-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)butan-2-yl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
peonidin 3-O-(6-O-(Z)-4-coumaroyl-beta-D-glucoside)
An anthocyanin cation that is peonidin substituted at position 3 by a 6-O-(cis-4 coumaryl)-beta-D-glucosyl residue.
peonidin 3-O-(6-O-(E)-4-coumaroyl-beta-D-glucoside)
An anthocyanin cation that is peonidin substituted at position 3 by a 6-O-(trans-4 coumaryl)-beta-D-glucosyl residue
SR 146131
SR 146131 is a potent, orally available, and selective nonpeptide (cholecystokinin 1) receptor agonist.
(3s,6r,9s,12s,14e,16r,18s)-6-[(3-bromo-4-hydroxyphenyl)methyl]-5,11-dihydroxy-9-(hydroxymethyl)-3,7,12,14,16,18-hexamethyl-1-oxa-4,7,10-triazacyclooctadeca-4,10,14-triene-2,8-dione
C28H40BrN3O7 (609.2049470000001)
(3s,6r,9r,12s,14e,16r,18s)-6-[(3-bromo-4-hydroxyphenyl)methyl]-5,11-dihydroxy-9-(hydroxymethyl)-3,7,12,14,16,18-hexamethyl-1-oxa-4,7,10-triazacyclooctadeca-4,10,14-triene-2,8-dione
C28H40BrN3O7 (609.2049470000001)